CNBC reports Eli Lilly obesity growth broadening across global markets
Demand for the company's incretin franchise is rising outside the United States as well as at home.
The wire
- 01CNBC reports that growth in Eli Lilly's obesity business is coming from markets around the world, not just the US.
- 02International demand shapes supply allocation and pricing that clinicians and telehealth operators encounter locally.
- 03No product-level figures or guidance changes accompany the report.
From the source
Read at cnbc.comImpressive growth of Eli Lilly's obesity business is coming from all over the world